Prepare for the Clinical Genetics Test. Utilize flashcards and multiple-choice questions, each with hints and explanations. Achieve success on your exam!

Multiple Choice

What is the clinical approach when a VUS is observed in a patient with a classic phenotype and supportive family history?

When a variant of uncertain significance is found in someone with a classic phenotype and a supportive family history, the goal is to clarify its role by gathering more evidence rather than making immediate conclusions. The key step is segregation analysis: test other affected and unaffected family members to see whether the variant tracks with disease. If the variant co-segregates with disease and the overall clinical picture fits, you re-evaluate the classification using current guidelines, incorporating segregation data, population frequencies, functional data if available, and other supportive information. With this accumulating evidence, the variant can be reclassified toward likely pathogenic or pathogenic, and it may be treated as probable pathogenic with caution, guiding management for the patient and offering appropriate cascade testing to relatives. If segregation does not support pathogenicity, the variant remains unlikely to be disease-causing, and management should reflect that uncertainty. Retesting with a different method is not the primary approach unless there is a specific reason to doubt the initial result, and ignoring the variant is inappropriate given the potential implications.

When a variant of uncertain significance is found in someone with a classic phenotype and a supportive family history, the goal is to clarify its role by gathering more evidence rather than making immediate conclusions. The key step is segregation analysis: test other affected and unaffected family members to see whether the variant tracks with disease. If the variant co-segregates with disease and the overall clinical picture fits, you re-evaluate the classification using current guidelines, incorporating segregation data, population frequencies, functional data if available, and other supportive information. With this accumulating evidence, the variant can be reclassified toward likely pathogenic or pathogenic, and it may be treated as probable pathogenic with caution, guiding management for the patient and offering appropriate cascade testing to relatives. If segregation does not support pathogenicity, the variant remains unlikely to be disease-causing, and management should reflect that uncertainty. Retesting with a different method is not the primary approach unless there is a specific reason to doubt the initial result, and ignoring the variant is inappropriate given the potential implications.